Gaithersburg vaccine maker Novavax Inc. (NASDAQ: NVAX) saw its share price spike for the second time this month, increasing 11 percent from $2.01 at Monday’s opening bell to $2.23 at the close of Tuesday trading. The price jump came just a few weeks after the company experienced a 50 percent jump that followed a company report about its clinical trials. That prompted an “uber-bullish" rating from an B. Riley FBR Inc. analyst, raising Novavax’s 12-month price target from $2.25 to $10. What gives…
from https://www.bizjournals.com/baltimore/news/2018/01/24/why-novavaxs-share-price-is-spiking-again.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/170074156997
No comments:
Post a Comment